|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 35 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-06 |
4 |
S |
$12.14 |
$373,269 |
I/I |
(30,747) |
600,151 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-06-27 |
4 |
S |
$15.41 |
$5,109,925 |
I/I |
(331,598) |
601,511 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-03-09 |
4 |
B |
$18.28 |
$1,139,358 |
I/I |
62,325 |
606,709 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-04-25 |
4 |
A |
$0.00 |
$0 |
I/I |
517,593 |
608,152 |
|
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-11 |
4 |
B |
$5.28 |
$107,365 |
I/I |
20,347 |
608,349 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-24 |
4 |
B |
$5.98 |
$25,386 |
I/I |
4,242 |
612,591 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-25 |
4 |
B |
$6.00 |
$76,206 |
I/I |
12,701 |
625,292 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-05 |
4 |
S |
$12.05 |
$47,439 |
I/I |
(3,936) |
630,898 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-02 |
4 |
S |
$11.88 |
$120,874 |
I/I |
(10,177) |
634,834 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-01 |
4 |
S |
$11.50 |
$93,364 |
I/I |
(8,118) |
645,011 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-31 |
4 |
S |
$11.70 |
$142,662 |
I/I |
(12,198) |
653,129 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-30 |
4 |
S |
$12.03 |
$194,539 |
I/I |
(16,173) |
665,327 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-05-24 |
4 |
B |
$5.25 |
$1,462,913 |
I/I |
278,650 |
667,288 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
officerTitle |
|
2006-03-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
674,120 |
|
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-29 |
4 |
S |
$12.47 |
$215,815 |
I/I |
(17,311) |
681,500 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-04-25 |
4 |
A |
$0.00 |
$0 |
I/I |
448,047 |
682,908 |
|
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
S |
$7.38 |
$14,060 |
I/I |
(1,906) |
696,905 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
B |
$7.30 |
$13,914 |
I/I |
1,906 |
698,811 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
N/A |
|
2006-09-08 |
4 |
B |
$14.12 |
$2,832,727 |
I/I |
199,911 |
713,044 |
0.01 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-12-22 |
4 |
B |
$3.85 |
$595,557 |
I/I |
154,646 |
771,212 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-06-11 |
4 |
OE |
$1.03 |
$152,174 |
I/I |
147,313 |
777,506 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2006-03-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
811,124 |
|
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-12-26 |
4 |
B |
$4.00 |
$331,992 |
I/I |
82,998 |
854,210 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-21 |
4 |
B |
$15.50 |
$4,157,844 |
I/I |
268,248 |
874,957 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-09 |
4 |
B |
$4.77 |
$118,733 |
I/I |
24,899 |
879,109 |
1.5 |
- |
|
1397 Records found
|
|
Page 35 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|